Quarterly report · Q2

Period2023-12-01 → 2024-05-31
Filed2024-07-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥4.2bn2023-12-01 → 2024-05-31Cons.Net sales
Revenue¥8.6bn2022-12-01 → 2023-11-30Cons.Net sales (5-year summary)
Revenue¥4.2bn2022-12-01 → 2023-05-31Cons.Net sales
Operating income¥202m2023-12-01 → 2024-05-31Cons.Operating income
Operating income¥156m2022-12-01 → 2023-05-31Cons.Operating income
Ordinary income¥212m2023-12-01 → 2024-05-31Cons.Ordinary income
Ordinary income¥345m2022-12-01 → 2023-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥156m2022-12-01 → 2023-05-31Cons.Ordinary income
Profit before tax¥252m2023-12-01 → 2024-05-31Cons.Income before income taxes
Profit before tax¥155m2022-12-01 → 2023-05-31Cons.Income before income taxes
Net income (owners)¥193m2023-12-01 → 2024-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥256m2022-12-01 → 2023-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥121m2022-12-01 → 2023-05-31Cons.Profit loss attributable to owners of parent
Net income¥193m2023-12-01 → 2024-05-31Cons.Profit loss
Net income¥121m2022-12-01 → 2023-05-31Cons.Profit loss
Total assets¥8.0bnat 2024-05-31Cons.Assets
Total assets¥8.3bnat 2023-11-30Cons.Assets
Total assets¥8.0bnat 2023-05-31Cons.Total assets (5-year summary)
Total liabilities¥5.3bnat 2024-05-31Cons.Liabilities
Total liabilities¥5.7bnat 2023-11-30Cons.Liabilities
Net assets / equity¥2.7bnat 2024-05-31Cons.Net assets
Net assets / equity¥2.6bnat 2023-11-30Cons.Net assets
Net assets / equity¥2.5bnat 2023-05-31Cons.Net assets (5-year summary)
Cash and deposits¥947mat 2024-05-31Cons.Cash and deposits
Cash and deposits¥1.0bnat 2023-11-30Cons.Cash and deposits
Cash & equivalents¥947mat 2024-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.0bnat 2023-11-30Cons.Cash and cash equivalents
Cash & equivalents¥999mat 2023-05-31Cons.Cash and cash equivalents
Cash & equivalents¥911mat 2022-11-30dCons.Cash and cash equivalents
Operating cash flow¥90m2023-12-01 → 2024-05-31Cons.Net cash provided by used in operating activities
Operating cash flow¥470m2022-12-01 → 2023-11-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥223m2022-12-01 → 2023-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥96m2023-12-01 → 2024-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥370m2022-12-01 → 2023-11-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥217m2022-12-01 → 2023-05-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥101m2023-12-01 → 2024-05-31Cons.Net cash provided by used in financing activities
Financing cash flow¥21m2022-12-01 → 2023-11-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥80m2022-12-01 → 2023-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥158.382023-12-01 → 2024-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥117.592024-03-01 → 2024-05-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥209.882022-12-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥99.172022-12-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥65.392023-03-01 → 2023-05-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio34.2%at 2024-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.6%at 2023-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio31.1%at 2023-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2023-12-01 → 2024-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2023-12-01 → 2024-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2023-12-01 → 2024-05-31¥187m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2023-12-01 → 2024-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2023-12-01 → 2024-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2023-12-01 → 2024-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2023-12-01 → 2024-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-12-01 → 2024-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-12-01 → 2024-05-31¥202m
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2022-12-01 → 2023-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2022-12-01 → 2023-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2022-12-01 → 2023-05-31¥141m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2022-12-01 → 2023-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2022-12-01 → 2023-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2022-12-01 → 2023-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-05-31¥156m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 480
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)海南監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)秋  葉   陽
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)米  川   博
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration4206904000JPY
Net sales (5-year summary)CurrentYTDDuration4248278000JPY
Net sales (5-year summary)Prior1YearDuration8610396000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration156261000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration211885000JPY
Ordinary income loss (5-year summary)Prior1YearDuration344577000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration120732000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration192827000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration255526000JPY
Comprehensive income (5-year summary)Prior1YTDDuration129929000JPY
Comprehensive income (5-year summary)CurrentYTDDuration172078000JPY
Comprehensive income (5-year summary)Prior1YearDuration287950000JPY
Net assets (5-year summary)Prior1QuarterInstant2480403000JPY
Net assets (5-year summary)CurrentQuarterInstant2749629000JPY
Net assets (5-year summary)Prior1YearInstant2638424000JPY
Total assets (5-year summary)Prior1QuarterInstant7970553000JPY
Total assets (5-year summary)CurrentQuarterInstant8041789000JPY
Total assets (5-year summary)Prior1YearInstant8340594000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration99.17
Basic earnings loss per share (5-year summary)CurrentYTDDuration158.38
Basic earnings loss per share (5-year summary)Prior1YearDuration209.88
Diluted earnings per share (5-year summary)Prior1YTDDuration-
Diluted earnings per share (5-year summary)CurrentYTDDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.311
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.342
Equity to asset ratio (5-year summary)Prior1YearInstant0.316
Net cash provided by used in operating activities (5-year summary)Prior1YTDDuration223197000JPY
Net cash provided by used in operating activities (5-year summary)CurrentYTDDuration89585000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration469930000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YTDDuration-217015000JPY
Net cash provided by used in investing activities (5-year summary)CurrentYTDDuration-96210000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration-370243000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YTDDuration79828000JPY
Net cash provided by used in financing activities (5-year summary)CurrentYTDDuration-100963000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration20858000JPY
Cash and cash equivalents (5-year summary)Prior1QuarterInstant999341000JPY
Cash and cash equivalents (5-year summary)CurrentQuarterInstant946977000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant1043816000JPY
Basic earnings loss per share (5-year summary)Prior1QuarterDuration65.39
Basic earnings loss per share (5-year summary)CurrentQuarterDuration117.59
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1220000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1220000
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant1220000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant1220000

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-11-30pass
balance sheet identityconsolidated 2024-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-11-30pass
statement vs summary · net assetsconsolidated 2024-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-05-31pass
statement vs summary · net income attributable to parentconsolidated 2023-12-01/2024-05-31pass
statement vs summary · operating cash flowconsolidated 2022-12-01/2023-05-31pass
statement vs summary · operating cash flowconsolidated 2023-12-01/2024-05-31pass
statement vs summary · revenueconsolidated 2022-12-01/2023-05-31pass
statement vs summary · revenueconsolidated 2023-12-01/2024-05-31pass
statement vs summary · total assetsconsolidated 2023-11-30pass
statement vs summary · total assetsconsolidated 2024-05-31pass